Recital 9, Regulation (EU) 2026/2348

In force

Commission Directive 2010/89/EU [Commission Directive 2010/89/EU of 6 November 2010 amending Council Directive 91/414/EEC to include quinmerac as active substance and amending Decision 2008/934/EC (OJ L 320, 7.12.2010, p. 3, ELI: http://data.europa.eu/eli/dir/2010/89/oj).] included quinmerac in Annex I to Directive 91/414/EEC as an active substance until 30 April 2021 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of quinmerac was extended three times, most recently by Implementing Regulation (EU) 2024/1206 until 31 December 2026.